EMA Portal To Speed Things Up For Parallel Distributors
Executive Summary
The European Medicines Agency says that its IRIS portal will reduce the time needed for parallel distributors to prepare and submit notifications.
You may also be interested in...
Faster Submissions For Orphan Designation Possible As EMA’s Online Portal Goes Live
The new portal is expected to provide an improved method for applying for and managing EU orphan drug designations.
New EU Filings
Obecabtagene autoleucel, Autolus Therapeutics’s investigational treatment for relapsed or refractory B cell precursor acute lymphoblastic leukemia, is among the latest products that have been filed for review by the European Medicines Agency for potential EU marketing approval.
Moment Of Truth For Seven EU Filings; Cytokinetics To Make Its Case For Heart Failure Drug
The CHMP, the European Medicines Agency’s human medicines committee, will this week decide whether a range of new medicines merit being approved.